How Analysts Rated Perrigo Company plc (NYSE:PRGO) Last Week?

September 16, 2018 - By Adrian Erickson

Perrigo Company plc (NYSE:PRGO) LogoInvestors sentiment increased to 1.18 in 2018 Q2. Its up 0.30, from 0.88 in 2018Q1. It increased, as 36 investors sold Perrigo Company plc shares while 104 reduced holdings. 47 funds opened positions while 118 raised stakes. 105.75 million shares or 2.70% more from 102.96 million shares in 2018Q1 were reported.
Proshare Advsrs Limited Com has 19,663 shares for 0.01% of their portfolio. Fifth Third Bancorporation invested in 0% or 441 shares. 13D Limited Liability Corp owns 149,249 shares. Fukoku Mutual Life Insur reported 785 shares. Silvercrest Asset Gp Limited Co invested 0.07% of its portfolio in Perrigo Company plc (NYSE:PRGO). Architects Inc holds 0% or 25 shares. Zeke Capital Advsr invested in 3,579 shares or 0.02% of the stock. Moreover, Fmr Limited Liability Company has 0.04% invested in Perrigo Company plc (NYSE:PRGO). Alphamark Limited owns 171 shares. Brinker Capital stated it has 8,236 shares. M&T Commercial Bank Corporation reported 7,203 shares. 50,265 were reported by Qs Investors Ltd Liability. Nippon Life Glob Americas has invested 0.18% in Perrigo Company plc (NYSE:PRGO). Comerica Savings Bank stated it has 0.02% in Perrigo Company plc (NYSE:PRGO). Franklin Res stated it has 0.33% in Perrigo Company plc (NYSE:PRGO).

Perrigo Company plc (NYSE:PRGO) Ratings Coverage

Among 9 analysts covering Perrigo Company plc (NYSE:PRGO), 1 have Buy rating, 1 Sell and 7 Hold. Therefore 11% are positive. Perrigo Company plc had 11 analyst reports since May 8, 2018 according to SRatingsIntel. RBC Capital Markets maintained it with “Sector Perform” rating and $67 target in Friday, August 10 report. The firm earned “Equal-Weight” rating on Wednesday, June 6 by Barclays Capital. As per Friday, August 10, the company rating was maintained by JP Morgan. The firm earned “Hold” rating on Friday, August 10 by Deutsche Bank. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, May 14. Wells Fargo maintained Perrigo Company plc (NYSE:PRGO) on Monday, May 14 with “Market Perform” rating. The rating was downgraded by Argus Research to “Hold” on Monday, July 30. The firm has “Market Perform” rating given on Tuesday, August 21 by Wells Fargo. Goldman Sachs downgraded the stock to “Sell” rating in Thursday, July 12 report. The stock of Perrigo Company plc (NYSE:PRGO) earned “Buy” rating by Cantor Fitzgerald on Tuesday, May 8. Below is a list of Perrigo Company plc (NYSE:PRGO) latest ratings and price target changes.

21/08/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $84 New Target: $77 Maintain
10/08/2018 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Sector Perform Old Target: $89 New Target: $67 Maintain
10/08/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $83 New Target: $75 Maintain
10/08/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Hold Old Target: $93 New Target: $78 Downgrade
30/07/2018 Broker: Argus Research Old Rating: Buy New Rating: Hold Downgrade
12/07/2018 Broker: Goldman Sachs Old Rating: Neutral New Rating: Sell Old Target: $78 New Target: $74 Downgrade
18/06/2018 Broker: Morgan Stanley Rating: Hold New Target: $85.0000
06/06/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Equal-Weight Old Target: $110 Downgrade
14/05/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $107.0000 Maintain
14/05/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $90 New Target: $84 Maintain

The stock decreased 2.44% or $1.84 during the last trading session, reaching $73.69. About 1.58 million shares traded or 10.23% up from the average. Perrigo Company plc (NYSE:PRGO) has declined 15.60% since September 16, 2017 and is downtrending. It has underperformed by 31.22% the S&P500.

Perrigo Company plc, together with its subsidiaries, develops, makes, markets, and distributes over-the-counter consumer goods and pharmaceutical products worldwide. The company has market cap of $10.08 billion. It offers OTC products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. It has a 44.1 P/E ratio. The firm also provides generic and specialty pharmaceutical prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations.

Another recent and important Perrigo Company plc (NYSE:PRGO) news was published by which published an article titled: “Health Care Has Been On Fire. Will The Uptrend Continue?” on September 07, 2018.

Perrigo Company plc (NYSE:PRGO) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.